Otsuka Wins Block On Cancer Drug Lonsurf's Generic Version

By Hannah Albarazi · August 16, 2023, 9:57 PM EDT

Otsuka Holdings Co. Ltd.'s Taiho unit nabbed a win Tuesday when a Delaware federal judge upheld its patent for the metastatic colorectal cancer drug treatment Lonsurf, likely keeping a generic version...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Taiho Pharmaceutical Co., Ltd. et al v. Eugia Pharma Specialities Ltd. et al

Case Number

1:19-cv-02309

Court

Delaware

Nature of Suit

Patent - Abbreviated New Drug Application(ANDA)

Date Filed

December 19, 2019